Amphetamines increase dopamine and worsen symptoms in people with schizophrenia and induce symptoms in people without (Curran et al. 2004). Second, antipsychotic drugs reduce dopamine activity and reduce the intensity of symptoms (Tauscher et al. 2014). Third, some candidate genes act on the production of dopamine or dopamine receptors.